Overview

Study of Ossium Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in the Setting of Crohn's Disease

Status:
Not yet recruiting

Trial end date:
2024-11-15

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the safety and feasibility of using Ossium vertebral Bone Marrow Derived Mesenchymal Stem Cells (vBM-MSC) to treat people with an ileal pouch anal anastomosis (IPAA) who develop a fistula in the setting of Crohn's disease of the pouch.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Amy Lightner

Collaborator:

Ossium Health, Inc.